Ascendis Pharma A/S (ASND) Competitors

Ascendis Pharma A/S (NASDAQ:ASND) and argenex (NASDAQ:ARGX) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Do insiders & institutionals hold more shares of ASND or ARGX?

60.3% of argenex shares are owned by institutional investors. 40.0% of Ascendis Pharma A/S shares are owned by company insiders. Comparatively, 2.4% of argenex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has preferable earnings and valuation, ASND or ARGX?

argenex has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than argenex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ascendis Pharma A/S	$393.54M	29.58	-$409.12M	-$6.28	-30.31
argenex	$2.25B	18.27	$833.04M	$19.50	34.48

Which has more risk and volatility, ASND or ARGX?

Ascendis Pharma A/S has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, argenex has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500.

Is ASND or ARGX more profitable?

argenex has a net margin of 40.98% compared to Ascendis Pharma A/S's net margin of -93.22%. argenex's return on equity of 21.06% beat Ascendis Pharma A/S's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ascendis Pharma A/S	-93.22%	N/A	-33.29%
argenex	40.98%	21.06%	18.25%

Does the media refer more to ASND or ARGX?

In the previous week, argenex had 32 more articles in the media than Ascendis Pharma A/S. MarketBeat recorded 41 mentions for argenex and 9 mentions for Ascendis Pharma A/S. argenex's average media sentiment score of 1.04 beat Ascendis Pharma A/S's score of 0.64 indicating that argenex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ascendis Pharma A/S	3 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
argenex	18 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer ASND or ARGX?

Ascendis Pharma A/S currently has a consensus price target of $223.67, suggesting a potential upside of 17.50%. argenex has a consensus price target of $746.81, suggesting a potential upside of 11.07%. Given Ascendis Pharma A/S's higher possible upside, equities analysts plainly believe Ascendis Pharma A/S is more favorable than argenex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ascendis Pharma A/S	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	3.00
argenex	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

Summary

argenex beats Ascendis Pharma A/S on 13 of the 17 factors compared between the two stocks.